Posted by Michael Wonder on 07 Jan 2019
Big pharma is caught between Wall Street and Trump on drug prices
4 January 2019 - Investors seeking growth as older blockbusters begin to fade.
Washington wants drug prices to fall. Wall Street wants stock prices to rise. For some of the world’s largest pharmaceutical companies, pleasing both sides could be a problem.
Last year, the industry promised restraint after President Donald Trump took aim at rising pharmaceutical costs. On 1 January, drug makers returned to their annual practice of regular increases, boosting prices for dozens of treatments, from hot-selling arthritis therapies to painkillers at the centre of the U.S. opioid epidemic.
